Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function

Y. Shi, C. He, C. Ma, T. Yu, Yingzi Cong, W. Cai, Z. Liu

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Abstract

    Smad nuclear interacting protein 1 (SNIP1) has been implicated in the pathogenesis of inflammatory bowel disease (IBD). However, the mechanisms involved are still largely unknown. Our results demonstrated that SNIP1 was markedly decreased in intestinal epithelial cells (IEC) from IBD patients compared with healthy controls. Impaired expression of SNIP1 caused a significant decrease of transepithelial electrical resistance but an increase of fluorescein isothiocyanate-dextran flux in Caco-2 monolayers, whereas overexpression of SNIP1 reversed such effects. Overexpression of SNIP1 also inhibited the activity of NF- B p65 and proinflammatory cytokine production (e.g., TNF-α, IL-1β, and IL-8) by IEC. Importantly, supplementation of exogenous SNIP1 significantly ameliorated intestinal mucosal inflammation in experimental colitis, characterized by less-severe intestinal epithelial barrier damage and decreased proinflammatory cytokine production. Our data thus demonstrated a novel mechanism whereby SNIP1 regulates intestinal inflammation through modulating intestinal epithelial barrier function. Targeting SNIP1 may provide a therapeutic approach for the treatment of IBD.

    Original languageEnglish (US)
    Pages (from-to)835-845
    Number of pages11
    JournalMucosal Immunology
    Volume11
    Issue number3
    DOIs
    StatePublished - May 1 2018

    Fingerprint

    Smad Proteins
    Nuclear Proteins
    Inflammation
    Inflammatory Bowel Diseases
    Epithelial Cells
    Cytokines
    Colitis
    Electric Impedance
    Interleukin-8
    Interleukin-1

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology

    Cite this

    Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function. / Shi, Y.; He, C.; Ma, C.; Yu, T.; Cong, Yingzi; Cai, W.; Liu, Z.

    In: Mucosal Immunology, Vol. 11, No. 3, 01.05.2018, p. 835-845.

    Research output: Contribution to journalArticle

    @article{111d1237a82e4b6ea44ac75058854af3,
    title = "Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function",
    abstract = "Smad nuclear interacting protein 1 (SNIP1) has been implicated in the pathogenesis of inflammatory bowel disease (IBD). However, the mechanisms involved are still largely unknown. Our results demonstrated that SNIP1 was markedly decreased in intestinal epithelial cells (IEC) from IBD patients compared with healthy controls. Impaired expression of SNIP1 caused a significant decrease of transepithelial electrical resistance but an increase of fluorescein isothiocyanate-dextran flux in Caco-2 monolayers, whereas overexpression of SNIP1 reversed such effects. Overexpression of SNIP1 also inhibited the activity of NF- B p65 and proinflammatory cytokine production (e.g., TNF-α, IL-1β, and IL-8) by IEC. Importantly, supplementation of exogenous SNIP1 significantly ameliorated intestinal mucosal inflammation in experimental colitis, characterized by less-severe intestinal epithelial barrier damage and decreased proinflammatory cytokine production. Our data thus demonstrated a novel mechanism whereby SNIP1 regulates intestinal inflammation through modulating intestinal epithelial barrier function. Targeting SNIP1 may provide a therapeutic approach for the treatment of IBD.",
    author = "Y. Shi and C. He and C. Ma and T. Yu and Yingzi Cong and W. Cai and Z. Liu",
    year = "2018",
    month = "5",
    day = "1",
    doi = "10.1038/mi.2017.95",
    language = "English (US)",
    volume = "11",
    pages = "835--845",
    journal = "Mucosal Immunology",
    issn = "1933-0219",
    publisher = "Nature Publishing Group",
    number = "3",

    }

    TY - JOUR

    T1 - Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function

    AU - Shi, Y.

    AU - He, C.

    AU - Ma, C.

    AU - Yu, T.

    AU - Cong, Yingzi

    AU - Cai, W.

    AU - Liu, Z.

    PY - 2018/5/1

    Y1 - 2018/5/1

    N2 - Smad nuclear interacting protein 1 (SNIP1) has been implicated in the pathogenesis of inflammatory bowel disease (IBD). However, the mechanisms involved are still largely unknown. Our results demonstrated that SNIP1 was markedly decreased in intestinal epithelial cells (IEC) from IBD patients compared with healthy controls. Impaired expression of SNIP1 caused a significant decrease of transepithelial electrical resistance but an increase of fluorescein isothiocyanate-dextran flux in Caco-2 monolayers, whereas overexpression of SNIP1 reversed such effects. Overexpression of SNIP1 also inhibited the activity of NF- B p65 and proinflammatory cytokine production (e.g., TNF-α, IL-1β, and IL-8) by IEC. Importantly, supplementation of exogenous SNIP1 significantly ameliorated intestinal mucosal inflammation in experimental colitis, characterized by less-severe intestinal epithelial barrier damage and decreased proinflammatory cytokine production. Our data thus demonstrated a novel mechanism whereby SNIP1 regulates intestinal inflammation through modulating intestinal epithelial barrier function. Targeting SNIP1 may provide a therapeutic approach for the treatment of IBD.

    AB - Smad nuclear interacting protein 1 (SNIP1) has been implicated in the pathogenesis of inflammatory bowel disease (IBD). However, the mechanisms involved are still largely unknown. Our results demonstrated that SNIP1 was markedly decreased in intestinal epithelial cells (IEC) from IBD patients compared with healthy controls. Impaired expression of SNIP1 caused a significant decrease of transepithelial electrical resistance but an increase of fluorescein isothiocyanate-dextran flux in Caco-2 monolayers, whereas overexpression of SNIP1 reversed such effects. Overexpression of SNIP1 also inhibited the activity of NF- B p65 and proinflammatory cytokine production (e.g., TNF-α, IL-1β, and IL-8) by IEC. Importantly, supplementation of exogenous SNIP1 significantly ameliorated intestinal mucosal inflammation in experimental colitis, characterized by less-severe intestinal epithelial barrier damage and decreased proinflammatory cytokine production. Our data thus demonstrated a novel mechanism whereby SNIP1 regulates intestinal inflammation through modulating intestinal epithelial barrier function. Targeting SNIP1 may provide a therapeutic approach for the treatment of IBD.

    UR - http://www.scopus.com/inward/record.url?scp=85047980846&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85047980846&partnerID=8YFLogxK

    U2 - 10.1038/mi.2017.95

    DO - 10.1038/mi.2017.95

    M3 - Article

    C2 - 29426045

    AN - SCOPUS:85047980846

    VL - 11

    SP - 835

    EP - 845

    JO - Mucosal Immunology

    JF - Mucosal Immunology

    SN - 1933-0219

    IS - 3

    ER -